Telomerase and breast cancer
Current therapies for breast cancer include treatments that are toxic and often result in drug resistance. Telomerase, a cellular reverse transcriptase that maintains the ends of chromosomes (telomeres), is activated in the vast majority of breast cancers (over 90% of breast carcinomas) but not in n...
Gespeichert in:
| Veröffentlicht in: | Breast Cancer Res |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2001
|
| Schlagworte: | |
| Online-Zugang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC138678/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11305948/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/bcr288 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|